Getting Started

How Peptides Are Taken: Routes, Timing and Why It Matters

Subcutaneous, intramuscular, intravenous, intranasal, oral and topical routes compared, plus why timing and reconstitution matter for some peptides.

Subcutaneous, intramuscular, intravenous, intranasal, oral and topical routes compared, plus why timing and reconstitution matter for some peptides.

Everhuman Labs Team

·

·

7 min read

·

Quick answer: Peptides are taken by whichever route lets the specific molecule reach circulation intact, which for most means subcutaneous injection into the fat beneath the skin. Swallowing is generally ineffective because digestive enzymes break amino acid chains apart, so oral use is limited to molecules engineered for it. Intramuscular, intravenous, intranasal and topical routes exist for particular compounds and each changes how a peptide is absorbed. No universal answer exists, and every instruction should come from the prescribing clinician and the pharmacy label.

How a peptide is taken is not a preference, and regarding it as one is the most common error in this area. Route determines how much of the molecule reaches circulation, how fast it arrives, and in several cases whether the compound has any effect at all. Two people taking the same peptide by different routes are not doing slightly different versions of the same thing.

Why the route changes the outcome

Bioavailability describes the share of an administered dose that reaches the bloodstream intact, and route is its largest single determinant. Intravenous administration is complete by definition, while every other route loses some fraction to absorption barriers, enzymatic breakdown or clearance.

Peptides are unusually sensitive to this because of what they are made of. Amino acid chains are exactly the substrate that digestive and tissue enzymes exist to cut, so any route exposing a peptide to that machinery costs a large and often unpredictable share of the dose. Unpredictability is the real problem rather than loss alone. Background on why the molecules behave this way is in this explanation of what peptides are structurally.

The routes, and what each one actually changes

Subcutaneous injection places the peptide in the fat layer between skin and muscle, where blood flow is modest and absorption is gradual over minutes to hours. Reliability plus simplicity is why this is the default for at home use: bioavailability is high, the technique is teachable, and slower absorption gives a smoother curve. The mechanics are covered in this guide to how peptide injections work.

Intramuscular injection reaches better perfused tissue, so absorption is faster and the peak higher and sharper, at the cost of a longer needle, more anatomical care and more discomfort. Intravenous administration puts the full dose into circulation immediately and belongs in a clinical setting, because removing the absorption step also removes every margin for error.

Intranasal delivery works for a small number of peptides by absorbing across the nasal mucosa, bypassing the gut and the liver, though bioavailability tends to be low and variable. Oral administration is generally ineffective for the reasons already described, except for molecules engineered with protective modifications and absorption enhancers. Topical application faces the skin barrier, which excludes most peptides from systemic absorption, although some cosmetic peptides act locally in the skin where that is the intended effect.

Why lyophilised powder has to be reconstituted

Many prescribed peptides arrive as a white freeze dried cake rather than a ready made liquid, and the reason is stability. Peptides in solution degrade through hydrolysis and can aggregate, so lyophilisation gives the product a far longer usable life. Powder form is a stability decision, not an inconvenience.

Reconstitution is the step of adding a sterile diluent back to the vial to redissolve the powder before use. The pharmacy specifies which diluent to use and how much, and bacteriostatic water is common because the preservative in it allows a multiple use vial to be entered more than once safely, as explained in this piece on what bacteriostatic water is and why it is used.

Technique during reconstitution affects the product. Directing the diluent down the inside wall of the vial rather than onto the powder, and swirling gently instead of shaking, avoids mechanical stress that can denature or aggregate a peptide. Storage also changes once the powder is dissolved. Step by step handling is covered in this guide to reconstituting peptides correctly, and the amounts always come from the pharmacy label.

Why timing relative to food and sleep matters for some compounds

Timing is not a universal rule, but for certain peptides it is part of how the compound is meant to work. Growth hormone release in humans is pulsatile and largest during slow wave sleep early in the night, so compounds acting on the pituitary to encourage that release are often given in a way that aligns with the body's own rhythm rather than opposing it.

Food matters because eating changes the hormonal background. A meal raises insulin and circulating glucose, and elevated insulin blunts growth hormone secretion, which is why instructions for some pituitary acting peptides reference a gap around eating. Compounds acting on other systems may have no relationship to meals, so a rule learned for one peptide should not be carried across to another.

Consistency is the part that generalises. Taking a compound at a similar point in the day makes it possible to attribute any change to the medication rather than to a moving schedule. Specific timing for any prescription comes from the prescribing clinician and the pharmacy label.

Why there is no universal answer

Peptides differ from each other far more than the shared label suggests. Half life ranges from minutes to days across the category, some compounds are stable in solution and others are not, and formulations differ between pharmacies. Any instruction that generalises across all peptides is describing a category that does not behave as one.

Person specific factors matter as much as compound specific ones. Body composition changes subcutaneous absorption, other medications can interact, and kidney and liver function affect clearance. Anyone following a fixed protocol from a forum is following someone else's prescription, written for a different body and often for a product of unknown contents, a difference set out in this comparison of research labelled peptides and prescribed ones.

Frequently Asked Questions

How do you take peptides?

Most peptides used clinically are taken by subcutaneous injection into the fat beneath the skin, because that route bypasses digestion and absorbs predictably. Other routes exist for particular compounds, including intramuscular, intravenous, intranasal and topical. The specific route and instructions for any prescription come from the prescribing clinician and the pharmacy label.

Why do people take peptides?

People generally investigate peptides for sleep quality, recovery from training, and age related changes in energy and body composition, often after other approaches have not closed the gap. Motivation is not the same as suitability, and a clinician may conclude that a different evaluation or no therapy is appropriate. The category is explained further in this overview of what peptide therapy means.

Can peptides be taken orally?

Peptides taken orally are broken apart by digestive proteases and cleared substantially by the liver before reaching circulation, so oral administration is ineffective for most of them. A few peptide medicines have been engineered with protective modifications that allow oral use, but that work is specific to individual molecules. Oral supplements marketed as peptides face the same absorption problem.

Does it matter what time of day peptides are taken?

Timing matters for some peptides and not for others, depending on the system the compound acts on. Compounds acting on the pituitary are often timed around sleep and around meals, because growth hormone release follows a daily rhythm and is blunted by insulin. Any timing instruction should come from the prescribing clinician rather than from a general rule.

What is reconstitution and why is it needed?

Reconstitution is the process of dissolving a freeze dried peptide powder in a sterile diluent before use. Peptides are supplied as powder because they degrade in solution, so removing the water extends shelf life considerably. The diluent, the amount and the storage instructions after mixing all come from the dispensing pharmacy.

Do side effects differ depending on the route?

Route affects both local and systemic reactions, since injection introduces site specific effects such as redness or bruising, while faster absorbing routes produce sharper peaks. Reported effects across the category are summarised in this overview of peptide side effects and the evidence behind them.

The honest summary

Route is a pharmacological decision made for a specific molecule, not a matter of taste. Subcutaneous injection dominates because most peptides cannot survive digestion and because that route is reliable and simple enough to be done at home. Changing the route changes the medicine.

What this article deliberately does not contain is any amount, volume, frequency or schedule, because those are properties of a specific prescription for a specific person and cannot be written generally without doing harm. The prescribing clinician and the pharmacy label are the only correct sources for those instructions.

References

Primary sources for the claims above. Where a study is preclinical, that is stated in the section it supports.

  1. Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorganic & medicinal chemistry. 2018. PMID 28720325.

  2. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal transduction and targeted therapy. 2025. PMID 40038239.

  3. Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Diabetes technology & therapeutics. 2014. PMID 25329935.

Compounded medications are not FDA-approved and are not the same as, nor a substitute for, FDA-approved products. Prescription products require an evaluation by a licensed provider who determines whether a prescription is appropriate. A prescription is not guaranteed. Individual results vary. Everhuman does not provide medical advice; clinical care is delivered by Arora Health.

See if sermorelin is right for you

The assessment is free and reviewed by a licensed clinician through Arora Health. A prescription is not guaranteed, and the clinician may decide treatment is not appropriate for you.

Start the free assessment

Subscribe for Everhuman updates

Clinical services are provided by licensed clinicians. Therapies offered are prescribed and/or recommended following a clinical evaluation, if appropriate. These therapies may include medications compounded by a state-licensed pharmacy.

IMPORTANT FDA DISCLOSURE: The peptide medications and therapies offered have not been approved by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.